TG Therapeutics Inc logo

TG Therapeutics Inc

STU:NKB2 (USA)   Ordinary Shares
€ 15.32 (+0.18%) May 27
75.95
P/B:
16.13
Market Cap:
€ 2.38B ($ 2.59B)
Enterprise V:
€ 2.29B ($ 2.49B)
Volume:
-
Avg Vol (2M):
2.02K
Also Trade In:

TG Therapeutics Inc Valuation Measures